Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies  by Bardallo Cruzado, Leonor et al.
nefrolog ia. 2015;35(3):296–303
Revista de la Sociedad Española de Nefrología
www.rev is tanef ro logia .com
Original article
Serum cystatin C levels in preterm newborns in our setting:
Correlation with serum creatinine and preterm pathologies
Leonor Bardallo Cruzadoa, Elena Pérez Gonzálezb,∗, Zoraima Martínez Martosc,
Carmen Bermudo Guitarted, Mercedes Granero Asencioa, Salud Luna Lagaresa,
Mariano Marín Patónb, Juan Polo Padillae
a UGC Neonatología, Hospital Universitario Virgen Macarena, Sevilla, Spain
b Unidad de Nefrología Pediátrica, UGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, Spain
c UGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, Spain
d UGC Bioquímica Clínica, Hospital Universitario Virgen Macarena, Sevilla, Spain
e Departamento de Bioestadística, Universidad de Sevilla, Sevilla, Spain
a r t i c l e i n f o
Article history:
Received 11 July 2014
Accepted 6 March 2015
Available online 10 July 2015
Keywords:
Cystatin C
Creatinine
Premature infant
a b s t r a c t
Background: Cystatin C (CysC) is a renal function marker that is not as inﬂuenced as crea-
tinine (Cr) by endogenous or exogenous agents, so it is proposed as a marker in preterm
infants.
Objectives: To determine serum CysC values in preterm infants during the ﬁrst week of life,
compared to Cr. To analyse alterations caused by prematurity diseases.
Method: The design involved a longitudinal, observational study of prospective cohorts.
Groups were based on gestational age (GA): Group A (24–27 weeks), Group B (28–33 weeks),
Group C (34–36 weeks). Blood samples were collected at birth, within 48–72h and after
7 days of life.
Statistics: SPSS v.20 softwarewasused. The statisticalmethods applied included chi-squared
test and ANOVA.
Results: A total of 109 preterm infants were included in the study. CysC levels were 1.54mg/l
(±0.28) at birth, 1.38mg/l (±0.36) within 48–72h of life, and 1.50mg/l (±0.31) after 7 days
(p<0.05). Cr levels were 0.64mg/dl (±0.17) at birth, 0.64mg/dl (±0.28) within 48–72h, and
0.56mg/dl (±0.19) after 7 days (P< .05). CysC values were lower in hypotensive patients
and in those with a respiratory disease (P< .05), and no alterations associated with other
diseases were observed. There were no differences in Cr levels associated with any disease.
Creatinine levels were higher in patients ≤1.500 g (P< .05).
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Conclusions: Serum CysC decreased within 48–72h of life, and this decline showed signif-
icance (P< .05). The levels increased after 7 days in all 3 GA groups, and there was no
difference in CysC levels among the groups. More studies in preterm infants with hypoten-
sion and respiratory disease are required. CysC is a better glomerular ﬁltration rate (GFR)
marker in ≤1.500 g preterm infants.
© 2015 The Authors. Published by Elsevier España, S.L.U. on behalf of Sociedad Española de
Nefrología. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Valores de cistatina C sérica en recién nacidos pretérmino en nuestro
medio. Relación con valores de creatinina sérica y patologías de la
prematuridad
Palabras clave:
Cistatina C
Creatinina
Pretérmino
r e s u m e n
Antecedentes: La cistatina C (CisC) es un marcador de función renal no tan inﬂuenciado como
la creatinina (Cr) por agentes endógenos o exógenos, por lo que se propone como marcador
en el pretérmino.
Objetivos: Determinar valores de CisC sérica en pretérminos en la primera semana de vida,
comparándola con la Cr. Analizar modiﬁcaciones por patologías de la prematuridad.
Método: Estudio longitudinal, observacional, de cohortes prospectivo.
Grupos por edad gestacional (EG): grupo A (24–27 semanas), grupo B (28–33 semanas),
grupo C (34–36 semanas). Se recogieron muestras de sangre al nacimiento, a las 48–72h y a
los 7días.
Estadística: Programa SPSS v.20. Métodos estadísticos utilizados 2 y ANOVA.
Resultados: N=109 pretérminos. CisC al nacimiento: 1,54mg/l (±0,28), a las 48–72h de vida:
1,38mg/l (±0,36), a los 7días: 1,50mg/l (±0,31) (p < 0,05). Cr al nacimiento: 0,64mg/dl (±0,17),
a las 48–72h: 0,64mg/dl (±0,28), a los 7días: 0,56mg/dl (±0,19) (p < 0,05). Valores de CisCmás
bajos en pacientes con patología respiratoria e hipotensos (p<0,05) sin modiﬁcación según
patologías restantes. No diferencias en valores de Cr según patología. Valores de creatinina
más altos en pacientes ≤500g (p<0,05).
Conclusiones: Descenso de CisC sérica a las 48–72h de vida, siendo esta caída en el tiempo sig-
niﬁcativa (p<0,05), ascenso a los 7días, en los 3 grupos de EG y sin diferencias en valores de
CisC entre los grupos. Se requieren más estudios en pretérminos con patología respiratoria
y situaciones de hipotensión. En ≤1.500 g la CisC es mejor marcador de ﬁltrado glomerular
(FG).
© 2015 The Authors. Publicado por Elsevier España, S.L.U. en nombre de Sociedad Española
de Nefrología. Este es un artículo Open Access bajo la licencia CC BY-NC-ND
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he best renal function assessment index is the estimation
f glomerular ﬁltration rate (GFR). Procedures for the mea-
urement of such ﬁltrate are based on the renal clearance of
xogenous or endogenous molecules. Creatinine is the most
ommonlyused endogenousmarker. Given that its production
s proportional to the muscular mass of individuals and that it
s not only freely ﬁltered by the glomerulus but also secreted
y the proximal tubule and, in addition serum Creatinine is
ot sensitive enough for the identiﬁcation of early stages of
enal damage. Serum Creatinine is not not the most adequate
arker for thepaediatric population in general and theneona-
al population in particular. As an alternative to creatinine,
everal biological markers have been suggested, cystatin C
Cys C) being the most commonly analysed.
Cys C is a non-glycosylated, low molecular weight
13,343Da), cationic protein, with 120 amino acids and two(http://creativecommons.org/licenses/by-nc-nd/4.0/).
disulphide bridges. It has a protective function: inhibition of
enzymes involved in protein metabolism, collagen catabolism
and cellular matrix degradation and possible involvement in
defense mechanisms against viral and bacterial infections.
This protein is regularly synthesised by most nucleated cells,
with a considerable distribution volume in bodily ﬂuids. At
the renal level, it is freely ﬁltered by the glomerulus, due to
its low molecular weight and positive charge at physiological
pH, and it is reabsorbed and catabolised by proximal tubu-
lar cells. Under normal conditions, urinary concentration is
very low if there is no tubular damage. It is not affected by
muscular mass, nutrition status, size, age, gender, serum pro-
teins, bilirubin or drugs, though it may present variations in
cases of thyroid dysfunction, tumours or inﬂammatory dis-
eases. Therefore, authors such as Filler1,2 recommend the use
of equations based onCys C, rather than the Schwartz formula
to estimate GFR in children.
GFR is low in foetal and neonatal life. It increases after birth
and reaches a maximum of 60ml/min/1.73m2 during the ﬁrst
015298 nefrolog ia. 2
3–5 weeks of life in normal-term and premature newborns
(NB).3 Approximately 7.36% of NB in our setting are preterm
and 1.25% weigh less than 1500g. This population requires a
more adequate ﬁltration marker than the current one due to
its physiological characteristics: low weight, low body mass
index, reduced muscular mass, tendency to early renal failure
arising from the prematurity itself, as well as from the added
pathology and the use of nephrotoxic drugs.
This study was planned because of the difﬁculty to iden-
tify Cys C reference values in neonates, since these values
are deﬁned in a reduced number of preterm newborns and
only during the ﬁrst 3 postnatal days. The conducted study
determines said values during the ﬁrst 7 days after delivery
by relating them with gestational age (GA) and serum levels of
creatinine.
Objectives
- To determine values of serum concentration of Cys C, as a
renal functionmarker, in pretermNBduring theﬁrstweekof
life in our population upon conducting a comparative study
with serum creatinine.
- To analyze if the serum concentration of Cys C and creati-
nine is modiﬁed due pathologies related to being premature
and/or nephrotoxic drugs.
Material and methods
This is a longitudinal, observational, prospective, cohort study.
It was conducted in the newborn intensive care unit on
preterm new born (NB) born in and/or admitted to the Hos-
pital Universitario Virgen Macarena de Sevilla from July 2010
to May 2012. The protocol was approved by the Ethics Com-
mittee of our centre. Informed consent was obtained from
the neonates’ legal representatives. Preterm newborns were
divided into three groups according to the (degree of prema-
turity) (GA): Group A (24–27 weeks), Group B (28–33 weeks)
and Group C (34–36 weeks). The analysed variables were GA,
weight, gender, administration of nephrotoxic drugs: antibi-
otics (cephotaxime, vancomicin, gentamicin), furosemide and
ibuprofen IV at different doses based on weight in kg, GA in
weeks and days of postnatal life, according to the NeofaxR
handbook, 2011 version. There was no pharmacokinetic con-
trol of the drugs that could potentially be monitored; there
was coexistence of associated respiratory pathologies (tran-
sient tachypnea or hyaline membrane of I–IV degree, which
increases according to the severity of the radiological pat-
tern), hypoxic ischaemic encephalopathy, acute renal failure
(ARF), intraventricular haemorrhage, necrotising enterocolitis,
sepsis and severe low blood pressure (blood pressure below
the third percentile, according to GA, gender and days of
life4). Blood, Cys C and creatinine samples were collected at
birth, at 48–72h of life and at 7 days. Blood samples were
obtained from arteries, veins or capillaries during the ﬁrst
7 days after delivery, when routine samples were collected.
Serum Cys C was measured through nephelometry (Particle-
EnhancedNephelometric Immuno-Assay) (BNII Siemens)with
an ERM-DA471/IFCC60 certiﬁcation that ensures its stan-
dardisation and traceability. Serum creatinine was measured;35(3):296–303
through the Jaffe method using the IDMS (isotope dilution
mass spectrometry)-standardised analyser, Cobas 6000 from
Roche.
To calculate the intra-assay precision of Cys C and
serum creatinine determinations, two different samples were
selected: a samplewithnormal values and apathological sam-
ple, with known concentrations in both cases; and these were
entered 21 consecutive times into the corresponding analysers
for each technique. As a result, we obtained the intra-assay
coefﬁcients of variation (CV) shown below:
Cystatin: at 1mg/l, CV: 2.9%; and at 2.1mg/l, CV: 2.9%.
Creatinine: at 1.8mg/l, CV: 2%; and at 8.5mg/l, CV: 1.2%.
Furthermore, to calculate the intra-assay precision of Cys
C and serum creatinine determinations, two samples with
known concentrations (once again, a normal sample and a
pathological sample) were selected and determined by dupli-
cate analysis during 10 consecutive days in the corresponding
analysers for each technique. As a result, we obtained the
inter-assay coefﬁcients of variation (CV) shown below:
Cystatin: at 1mg/l, CV 2.6%; and at 2.1mg/l, CV 2.4%.
Creatinine: at 1.8mg/l, CV 3.7%; and at 8.5mg/l, CV 2.8%.
The statistical analysis was performed using the SPSS v.20
software, and the statistical methods used included the x2
method and the variance analysis of repeated measures on
one factor. The p<0.05 value was considered statistically sig-
niﬁcant.
Results
Total number of studied preterm newborns (n) was 109; 62
(56.9%) were male individuals and 47 (43.1%) female individ-
uals. There were no differences among GA groups based on
gender (p=0.97). Group A had 10 preterm newborns; group B
had 50 preterm newborns; and group C had 49 preterm new-
borns.
Mean GA of the studied population was 32 weeks, range:
24–36 weeks. For Group A it was 26 weeks; range: 24–27
weeks, for Group B 31 weeks; range: 28–33 weeks and Group C
35 weeks; range: 34–36 weeks.
Mean weight of the studied population was 1767g, range:
620–3505 g. For Group A it was 911g; range: 620–1210 g, for
GroupB1612g; range: 845–2435 g and forGroupC2099g; range:
1260–3505 g.
Table 1 shows the values of serum Cys C and creatinine at
birth, at 48–72h and at the ﬁrst week of life, as well as the
values in each subgroup of the population. Fig. 1a shows
the changes in the values of Cys C in each GA group over time.
There is a decrease in the serum concentration of Cys C at
48–72h of life and an increase at 7 days (p<0.05). This decrease
over time occurs in the 3 GA groups, and, though the values
of Cys C are higher as the GA of preterm newborns increases,
there are no differences among groups (p=0.07).
Fig. 1b shows the changes in the values of creatinine in
each GA group over time. There is a decrease over time, and
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Fig. 1 – (a) Cys values arranged by GA group (p=0.07)
and postnatal days of life (p<0.05). (b) Creatinine values
arranged by GA group (p=0.11) and postnatal days of life
(p<0.05).
serum concentrations are lower at 7 days (p<0.05). However,
there were no differences among GA groups (p=0.11).
Fig. 2a shows how serum Cys C continues to decrease at
48–72h depending on the presence or absence of respiratory
pathology, and how it increases at 7 days (p<0.05). Besides, it
shows that the concentration of Cys C is lower in the group
with respiratory pathology (p<0.05). Fig. 2b shows that serum
creatinine decreases over time depending on the presence or
absence of respiratory pathology, with lower values at 7 days
(p<0.05). However, there are no differences in the values of
creatinine among groups based on the presence or absence
of respiratory pathology (p=0.73).
Fig. 2c shows that serum Cys C continues to decrease at
48–72h of life and that it increases at 7 days in both weight
groups (p<0.05). There are no differences among groups
>1500g compared to ≤1500 (p=0.08). Fig. 2d shows that serum
creatinine continues to decrease over time in both weight
groups (p<0.05), and creatinine values are higher in the group
≤1500g (p<0.05).
Fig. 2e shows the values of Cys C in relation to blood
pressure ﬁgures. Serum Cys C values are slightly lower in
patients with low blood pressure (p<0.05) during the ﬁrst 48h
300 nefrolog ia. 2015;35(3):296–303
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Fig. 2 – (a and b) Serum Cys C and creatinine values arranged by respiratory pathology and postnatal days of life. (c and d)
Serum Cys C and creatinine values arranged by weight and postnatal days of life. (e and f) Serum Cys C and creatinine
values.
compared to patients with normal blood pressure. These val-
ues subsequently increase in both groups. Creatinine values
increase at 48h in patients with low blood pressure, and these
values decrease at the ﬁrst week of life (p<0.05). These ﬁg-
ures are more stable in patients with normal blood pressure
(p=0.59) (Fig. 2f).
The decrease in serum Cys C at 48–72h of life and the
increase at 7 days also depend on whether nephrotoxic drugsare administered or not, there being no differences in the val-
ues of Cys C among groups (p=0.61). In relation to creatinine, it
continues to decrease over time (p<0.05), without there being
differences between both groups (p=0.94). (Table 2).
No group statistical analysis was not conducted to deter-
mine the presence or absence of the following pathologies:
hypoxic ischaemic encephalopathy (n=3), acute renal failure
(ARF) (n=3), intraventricular haemorrhage (n=3), necrotising
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enterocolitis (n=3) or neonatal sepsis (n=5), due to the low
incidence of these pathologies in the studied population.
Discussion
It is widely known that serum Cys C values are very high in
neonates and that these are exclusively related to NB, since
serum Cys C does not cross the placental barrier as creatinine,
which comes from both mothers and NB.
Upon determination of GFR, Cys C provides better sensitiv-
ity (97%) and speciﬁcity (96%) than creatinine (83% and 87%,
respectively),5,6 which is supported by recent studies where
Cys C reference ﬁgures are determined in both preterm NB
and term NB from different populations.7,8 The objective of
this study was not to estimate GFR in our population, but
rather serum concentration of Cys C in preterm newborns;
thus, the GFR rate is not mentioned in the study. However,
it is worth mentioning the reference method used for the
measurement of GFR in these patients. There are different
estimation equations based on creatinine, Cys C and both
endogenous markers. These equations arise from a newborn
population with speciﬁc characteristics (in relation to age
and chronic renal disease stage) and from certain procedures
for the measurement and calibration of several endogenous
markers, which differ from equations used for the adult pop-
ulation. The most commonly used estimation equation based
on creatinine is the Schwartz equation. It was originally pub-
lished in 1976. It is called the original Schwartz equation. In
2009, the original equation was updated and it is currently
knownas theupdatedormodiﬁedSchwartz equation. The cre-
atinine measurement procedure in the lab in this equation is
an enzymatic procedure with IDMS traceability (standardised
creatinine). It is the ﬁrst paediatric estimation equation with
standardised creatinine based on the size of the patient, 2009
updated Schwartz equation (ml/min/1.73m2) [K× size]/pCr,
where K is 0.413, with size in cm and plasma creatinine (pCr)
in mg/dl.
Equations based on serum Cys C are simpler than
equations based on creatinine, since the former do not
include anthropometric data: Filler, 2003 (ml/min/1.73m2)
91.62×CysC-1.123 (cystatin C: mg/l).
The results of our study show that Cys C values pro-
gressively decrease at 48–72h of life, this decrease being
statistically signiﬁcant over time (p<0.05), followed by an
increase at 7 days. This decrease over time occurs in the 3GA
groups, and, though the values of Cys C are higher as the GA of
preterm newborns increases, there are no statistically signif-
icant differences among GA groups. However, Je-Hyan found
that serum levels of Cys C tend to decrease as GA increases,
as from the third postpartum day.9 However, we have found
certain concordance with studies that show lower values
of serum Cys C in bigger preterm newborns, which means
that serum Cys C might be affected by renal immaturity that
favours excessive urinary loss in more immature newborns,
10,11compared to term newborns. Interestingly, according to
some authors, newborns with low birth weight have higher
serum levels of Cys C during childhood.12 The speciﬁc mean-
ing of high serum levels of Cys C during the ﬁrst days of life is
015
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still unknown, but it may be related to its excretion difﬁculty
secondary to tubular immaturity.13
Regarding its association with a concomitant
pathology,14,15 there are statistically signiﬁcant differ-
ences in the values of Cys C in patients with respiratory
pathology, and the lowest values are observed in patients
with said pathology. We have not determined the exact cause
of said values. Elmas et al. observed lower values of Cys C
in neonates with respiratory distress, which makes it an
independent predictor of acute renal failure even in patients
with distress.16
This also occurs in cases of haemodynamic instability.
Although Cys C values are lower in patients with low blood
pressure, they remain more stable over time than creatinine
values, which increase more abruptly at 48h of life. Having
said that, we did not ﬁnd a cause for decreased Cys C values
in this case either. This could be related to a greater urinary
loss of urine Cys C as a result of renal lesion associated with
renal hypoperfusion, although this is currently just a study
hypothesis. Besides, an inverse correlation between pressure
and serum creatinine and Cys C is to be expected, as shown
by CL. Abitbol et al. in their study,17 although it is unknown
whether, in cases where low blood pressure persists, Cys C
urinary losses could increase and Cys C blood levels could
decrease. In our population, it is also true that we found a
small sample size of neonates with low blood pressure, which
could affect the data and the statistical signiﬁcance. Patients
with systolic pressure measurements below the third per-
centile for their age group were considered severe low blood
pressure cases. These cases could be due to perinatal hypoxia,
severe intraventricular haemorrhage, sepsis, severe entero-
colitis or congenital cardiopathies, which make it difﬁcult to
obtain a representative sample for the study due to the low
incidence of these pathologies in the population studied18,19
during the ﬁrst week of life.
In the study conducted by CL. Abitbol et al.17 creatinine
and Cys C values were also related to the administration
of nephrotoxic drugs, especially gentamicin, without there
being signiﬁcant differences among preterm newborns who
received these drugs and those who did not receive them. We
also did not ﬁnd statistically signiﬁcant differences amongCys
C values in neonates treatedwith nephrotoxic drugs and those
who were not treated. This is probably due to the better con-
trol of said drugs and the reasonable use of these medications,
which would reduce the risk of toxicity.
In our study, serum creatinine values decreased in preterm
newborns, and lower values were observed at 7 days of
life. Statistically signiﬁcant differences in creatinine values
according to weight are evidenced. Patients ≤1500g present
higher values, unlike Cys C values, where there are no statis-
tically signiﬁcant differences.20
It was difﬁcult to assess the increase in Cys C in sub-
jects with ARF because very few individuals presented that
pathology in our sample. A possibility would be to consider a
subclinical assessment of acute renal disease, or the adequate
management of liquids in this population, which could reduce
the risk of renal disease. In relation to the sepsis parameter,we
could not assess Cys C values because of the small sample of
patients with conﬁrmed sepsis. Y Li published changes in the
values of IL-18 in neonates with sepsis, but not modiﬁcations;35(3):296–303
in the values of Cys C as a predictor of independent risk for
ARF.21
There are several limitations in this study. Firstly, it is dif-
ﬁcult to determine which subjects are “healthy”, although
we tried to classify patients according to the clinical sever-
ity of their pathologies associated with prematurity. Subjects
may have different degrees of disease severity, may be subject
to different mechanic breathing modalities and may have a
certain degree of subclinical renal failure, which is inherent
to their immaturity. Secondly, we could not standardise levels
in the ﬁrst group, because this is for a smaller and statistically
less valuable group.
Conclusions
Serum Cys C decreases at 48–72h of life, this decrease being
statistically signiﬁcant over time (p<0.05), followed by an
increase at 7 days. This decrease over time occurs in the
3GA groups, and, though the values of Cys C are higher as
the GA of preterm newborns increases, there are no statisti-
cally signiﬁcant differences in Cys C values among GA groups.
These changes are probably due to the maturation of renal
function.
Statistically signiﬁcant differences in serum creatinine val-
ues are evidenced when groups are divided according to
weight ≤1500g or >1500g (p<0.05), and creatinine levels are
higher in patients with lower weight, although this differ-
ence is not present with serum Cys C. Thus, Cys C is a better
GFR marker in very preterm newborns,22 since its values are
less variable for the determination of the renal function in
neonates23 and it is independent of body mass.
Lower Cys C values are found in cases of haemodynamic
instability as well as in preterm newborns with associated
respiratory pathology. However, more studies are needed for
the identiﬁcation of the exact measures of Cys C, creatinine
and GFR in preterm newborns, taking into account that slight
increases in serum creatinine probably indicate renal lesion,
especially in this vulnerable population. Renal damage during
the neonatal period and its subsequent follow-up should be
assessed.
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